Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea.
J Glob Health. 2024 Sep 6;14:05025. doi: 10.7189/jogh.14.05025.
BACKGROUND: There is limited evidence on the effectiveness of the existing rehabilitation interventions for old adults with long coronavirus disease (COVID), which is of particular concern among old adults. METHODS: We systematically searched studies published in PubMed, EMBASE, Web of Science, Scopus, and Cochrane Library databases from their inception to 15 November 2023. Randomised controlled trials (RCTs) compared rehabilitation interventions with other controls in old adults (mean/median age of 60 or older) with long COVID were included. We performed a meta-analysis to compare the effects of the rehabilitation interventions with the common control group. Mean difference (MD) or standardised mean difference (SMD) with its 95% confidence intervals (CI) were used as summary statistics. Moreover, subgroup analyses based on the intervention programmes, the severity of acute infection, and the age of participants were carried out. RESULTS: A total of 11 RCTs involving 832 participants (64.37 ± 7.94 years, 52.2% were men) were included in the analysis. Compared with the control groups, rehabilitation interventions significantly improved 6-minute walking test (6 MWT; MD = 15.77 metres (m), 95% CI = 5.40, 26.13, P < 0.01), 30-second sit-to-stand test (MD = 4.11 number of stands (n), 95% CI = 2.46, 5.76, P < 0.001), all aspects of quality of life, independence in activities of daily living (SMD = 0.31, 95% CI = 0.14, 0.48, P < 0.001), and relieved fatigue (SMD = -0.66, 95% CI = -1.13, -0.19, P < 0.01), depression (SMD = -0.89, 95% CI = -1.76, -0.02, P < 0.05) and anxiety (SMD = -0.81, 95% CI = -1.58, -0.05, P < 0.05). However, the improvement of hand grip strength and pulmonary function was not statistically significant (P > 0.05). Subgroup analyses showed that improvements in 6 MWT, fatigue, anxiety, and depression were more pronounced in old patients who received exercise training, while those who received respiratory rehabilitation had more pronounced improvements in pulmonary function and quality of life. CONCLUSIONS: Old adults with long COVID who underwent rehabilitation interventions experienced significant improvement in functional capacity, fatigue, quality of life, independence in activities of daily living, and mental health outcomes compared with usual/standard care. These findings suggest that screening, management, and rehabilitation interventions for long COVID in older adults should be strengthened to improve their complete health status and functional status, thereby reducing the long-term disease burden caused by long COVID and fostering healthy aging during the post-pandemic era.
背景:目前针对长新冠老年患者的康复干预措施的有效性证据有限,这在老年患者中尤为令人关注。
方法:我们系统地检索了从成立到 2023 年 11 月 15 日在 PubMed、EMBASE、Web of Science、Scopus 和 Cochrane Library 数据库中发表的研究。纳入了比较康复干预与长新冠老年患者(平均/中位数年龄 60 岁及以上)其他对照组的随机对照试验(RCT)。我们进行了荟萃分析,以比较康复干预与常见对照组的效果。使用均数差值(MD)或标准化均数差值(SMD)及其 95%置信区间(CI)作为汇总统计数据。此外,还进行了基于干预方案、急性感染严重程度和参与者年龄的亚组分析。
结果:共纳入 11 项 RCT,涉及 832 名参与者(64.37±7.94 岁,52.2%为男性)。与对照组相比,康复干预显著改善了 6 分钟步行测试(6MWT;MD=15.77 米(m),95%CI=5.40,26.13,P<0.01)、30 秒坐站测试(MD=4.11 次站立(n),95%CI=2.46,5.76,P<0.001)、所有方面的生活质量、日常生活活动的独立性(SMD=0.31,95%CI=0.14,0.48,P<0.001)和疲劳缓解(SMD=-0.66,95%CI=-1.13,-0.19,P<0.01)、抑郁(SMD=-0.89,95%CI=-1.76,-0.02,P<0.05)和焦虑(SMD=-0.81,95%CI=-1.58,-0.05,P<0.05)。然而,握力和肺功能的改善没有统计学意义(P>0.05)。亚组分析表明,接受运动训练的老年患者在 6MWT、疲劳、焦虑和抑郁方面的改善更为明显,而接受呼吸康复的患者在肺功能和生活质量方面的改善更为明显。
结论:与常规/标准护理相比,接受康复干预的长新冠老年患者在功能能力、疲劳、生活质量、日常生活活动独立性和心理健康结局方面有显著改善。这些发现表明,应加强对老年长新冠患者的筛查、管理和康复干预,以改善其整体健康状况和功能状况,从而减轻长新冠长期带来的疾病负担,并在疫情后时代促进健康老龄化。
Cochrane Database Syst Rev. 2016-11-24
Cochrane Database Syst Rev. 2015-2-23
Cochrane Database Syst Rev. 2022-2-1
Cochrane Database Syst Rev. 2022-8-22
Cochrane Database Syst Rev. 2020-1-31
Cochrane Database Syst Rev. 2021-2-1
Cochrane Database Syst Rev. 2016-12-21
Cochrane Database Syst Rev. 2012-8-15
Biomedicines. 2023-11-8
J Pharmacopuncture. 2023-9-30
Respirology. 2023-11